AI assistant
BIO-TECHNE Corp — Director's Dealing 2022
Aug 17, 2022
30718_dirs_2022-08-17_7ea196c8-7cd3-4dae-b6ea-5ccbfe2a6897.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-08-15
Reporting Person: Furlow Brenda S. (SVP - General Counsel)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-15 | Stock Options (Right to Buy) | $378.08 | A | 6166 | Acquired | 2029-08-15 | Common Stock (6166) | Direct |
| 2022-08-15 | Restricted Stock Units | $ | A | 1984 | Acquired | Common Stock (1984) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6523 | Direct |
| Common Stock | 1330 | Indirect |
| Common Stock | 1330 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $177.3200 | 2025-08-08 | Common Stock (16562) | 16562 | Direct |
| Stock Options (Right to Buy) | $190.4100 | 2026-08-07 | Common Stock (9968) | 9968 | Direct |
| Stock Options (Right to Buy) | $190.4100 | 2026-08-07 | Common Stock (13290) | 13290 | Direct |
| Restricted Stock Units | $ | Common Stock (1679) | 1679 | Direct | |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (7492) | 7492 | Direct |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (9990) | 9990 | Direct |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Options (Right to Buy) | $372.4400 | 2028-03-01 | Common Stock (10997) | 10997 | Direct |
| Restricted Stock Units | $ | Common Stock (1167) | 1167 | Direct | |
| Stock Options (Right to Buy) | $481.8200 | 2028-08-06 | Common Stock (4560) | 4560 | Direct |
| Stock Options (Right to Buy) | $481.8200 | 2028-08-06 | Common Stock (6080) | 6080 | Direct |
| Stock Options (Right to Buy) | $125.0500 | 2024-08-09 | Common Stock (9503) | 9503 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: Options to purchase 1,542 shares vest on each of 8/15/2023 and 8/15/2025 and options to purchase 1,541 shares vest on 8/15/2024 and 8/15/2026.
F3: 661 shares vest on each of 8/15/2023 and 8/15/2025, and 662 shares vest on 8/15/2024.
F4: Fully exercisable.
F5: On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs.
F6: Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
F7: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: Options to purchase 2,497 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,498 shares vest on each of 8/5/2023 and 8/5/2024.
F9: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F10: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F11: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F12: Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.